Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

"Can Growth Hormone's Lipolytic and Insulin-Antagonistic Effects be Modified by Peroxisome Proliferator-Activated Gamma Agonists?"

NCT00459940 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.

NCT NCT00459940
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00459940 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
"Can Growth Hormone's Lipolytic and Insulin-Antagonistic Effects be Modified by Peroxisome Proliferator-Activated Gamma Agonists?"
Lead sponsor
University of Aarhus
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2004
Completion date
March 31, 2006
Enrollment
20
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

growth hormone deficiency